NO20072609L - Malonamid-derivater - Google Patents
Malonamid-derivaterInfo
- Publication number
- NO20072609L NO20072609L NO20072609A NO20072609A NO20072609L NO 20072609 L NO20072609 L NO 20072609L NO 20072609 A NO20072609 A NO 20072609A NO 20072609 A NO20072609 A NO 20072609A NO 20072609 L NO20072609 L NO 20072609L
- Authority
- NO
- Norway
- Prior art keywords
- lower alkyl
- halogen
- hydroxy
- substituted
- cycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
I Oppfinnelsen angår forbindelser med den generelle formel I hvor R er halogen, lavere alkyl eller lavere alkyl substituert med halogen; R1 er hydrogen, lavere alkyl eller lavere alkyl substituert med halogen eller hydroksy eller er lavere alkenyl, -(CH2)n-cykloalkyl, -(CH2)n-COR' eller er benzyl, eventuelt substituert med halogen eller er -(CH2)n-morfolinyl; R' er lavere alkoksy, hydroksy eller amino; R2 er hydrogen, lavere alkyl eller di-lavere alkyl, lavere alkyl substituert med halogen eller hydroksy eller er benzyl eller cykloalkyl; R3 er lavere alkyl eller lavere alkyl substituert med halogen eller er benzyl, eventuelt substituert med to halogenatomer eller er -(CH2)n-cykloalkyl eller -(CH2)n-pyridinyl; X er -CR4R4'- eller - CR4R4'-O-; R4/R4' er uavhengig av hverandre hydrogen, halogen, lavere alkyl, lavere alkoksy, hydroksy eller -CH2-2-[1,3]dioksalan-; n er 0, 1 eller 2; farmasøytisk egnede syreaddisjonssalter derav og alle former av optisk rene enantiomerer, racemater eller diastereomerer og diastereomer-blandinger derav for behandling av Alzheimer's sykdom.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04106395 | 2004-12-08 | ||
| EP05100816 | 2005-02-07 | ||
| PCT/EP2005/012834 WO2006061136A2 (en) | 2004-12-08 | 2005-12-01 | Malonamide derivatives as inhibitors of gamma-secretase for the treatment of alzheimer’s disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20072609L true NO20072609L (no) | 2007-06-19 |
Family
ID=36293585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20072609A NO20072609L (no) | 2004-12-08 | 2007-05-24 | Malonamid-derivater |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7211573B2 (no) |
| EP (1) | EP1828151B1 (no) |
| JP (1) | JP4979590B2 (no) |
| KR (1) | KR100890678B1 (no) |
| CN (1) | CN101072760B (no) |
| AR (1) | AR053987A1 (no) |
| AT (1) | ATE504580T1 (no) |
| AU (1) | AU2005313582B8 (no) |
| BR (1) | BRPI0518615A2 (no) |
| CA (1) | CA2589196A1 (no) |
| DE (1) | DE602005027388D1 (no) |
| DK (1) | DK1828151T3 (no) |
| HK (1) | HK1114840A1 (no) |
| IL (1) | IL183293A0 (no) |
| MX (1) | MX2007006504A (no) |
| NO (1) | NO20072609L (no) |
| NZ (1) | NZ555184A (no) |
| PL (1) | PL1828151T3 (no) |
| PT (1) | PT1828151E (no) |
| RU (1) | RU2402538C2 (no) |
| TW (1) | TWI349005B (no) |
| WO (1) | WO2006061136A2 (no) |
| ZA (1) | ZA200705018B (no) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101096476B1 (ko) | 2006-09-20 | 2011-12-20 | 에프. 호프만-라 로슈 아게 | 4-옥소-2,3,4,5-테트라히드로-벤조[ｂ][1,4]디아제핀 유도체 |
| WO2008092786A1 (en) * | 2007-02-02 | 2008-08-07 | F. Hoffmann-La Roche Ag | 6-oxo-6,7-dihydro-5h-dibenzo[b,d]azepin-7-yl derivatives |
| US8741889B2 (en) * | 2008-01-11 | 2014-06-03 | Hoffmann-La Roche Inc | Method of treating non-small cell lung cancer and colon cancer with gamma-secretase inhibitor |
| BRPI0906831A2 (pt) * | 2008-01-11 | 2019-09-24 | Hoffmann La Roche | uso de um inibidor de gama-secretase para tratamento de câncer |
| CN107438599B (zh) * | 2015-06-11 | 2021-12-10 | 豪夫迈·罗氏有限公司 | 靶向Notch通路抑制剂 |
| WO2019081486A1 (en) | 2017-10-24 | 2019-05-02 | Bayer Aktiengesellschaft | 4H-PYRROLO [3,2-C] PYRIDIN-4-ONE DERIVATIVES |
| KR20210088619A (ko) * | 2018-11-07 | 2021-07-14 | 추가이 세이야쿠 가부시키가이샤 | O-치환 세린 유도체의 제조 방법 |
| US20240307362A1 (en) | 2019-04-24 | 2024-09-19 | Bayer Aktiengesellschaft | 4H-PYRROLO[3,2-c]PYRIDIN-4-ONE COMPOUNDS |
| EP3958865A1 (en) | 2019-04-24 | 2022-03-02 | Bayer Aktiengesellschaft | 4h-pyrrolo[3,2-c]pyridin-4-one derivatives |
| PE20220254A1 (es) | 2019-04-24 | 2022-02-16 | Bayer Ag | Compuestos de 4h-pirrolo[3,2-c]piridin-4-ona |
| CN112300019A (zh) * | 2019-07-31 | 2021-02-02 | 华东师范大学 | 一种邻乙酰氨基苯丁酸类化合物的制备方法 |
| WO2021198020A1 (en) | 2020-03-31 | 2021-10-07 | Bayer Aktiengesellschaft | 3-(anilino)-2-[3-(3-alkoxy-pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one derivatives as egfr inhibitors for the treatment of cancer |
| BR112023018000A2 (pt) | 2021-03-09 | 2023-10-03 | Basf Se | Compostos, composição, uso de um composto e método para controlar a vegetação indesejada |
| AR126867A1 (es) * | 2021-08-25 | 2023-11-22 | Basf Se | Malonamidas herbicidas |
| EP4396173A1 (en) * | 2021-08-31 | 2024-07-10 | Basf Se | Herbicidal malonamides containing a condensed ring system |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002241368A (ja) * | 1997-02-18 | 2002-08-28 | Shionogi & Co Ltd | 新規ベンゾラクタム誘導体およびそれを含有する医薬組成物 |
| WO1999067219A1 (en) * | 1998-06-22 | 1999-12-29 | Elan Pharmaceuticals, Inc. | Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| GB0012671D0 (en) | 2000-05-24 | 2000-07-19 | Merck Sharp & Dohme | Therapeutic agents |
| DK1511718T3 (da) * | 2002-05-29 | 2009-06-22 | Hoffmann La Roche | N-acylaminobenzenderivater som selektive monoaminoxidase B-inhibitorer |
| TW200502221A (en) * | 2002-10-03 | 2005-01-16 | Astrazeneca Ab | Novel lactams and uses thereof |
| DE602004015415D1 (de) | 2003-02-04 | 2008-09-11 | Hoffmann La Roche | Malonamidderivate als gamma-secretaseinhibitoren |
| US7060698B2 (en) | 2003-05-19 | 2006-06-13 | Hoffmann-La Roche Inc. | Benzoxazepinone derivatives |
| WO2005023772A1 (en) | 2003-09-09 | 2005-03-17 | F. Hoffmann-La Roche Ag | Malonamide derivatives blocking the activity of gama-secretase |
| JP4503607B2 (ja) | 2003-10-06 | 2010-07-14 | エフ．ホフマン−ラ ロシュ アーゲー | γ−セクレターゼ阻害剤として有用な置換ジベンゾアゼピンおよびベンゾジアゼピン誘導体 |
-
2005
- 2005-11-30 US US11/289,176 patent/US7211573B2/en not_active Expired - Fee Related
- 2005-12-01 PT PT05811672T patent/PT1828151E/pt unknown
- 2005-12-01 RU RU2007120211/04A patent/RU2402538C2/ru not_active IP Right Cessation
- 2005-12-01 DE DE602005027388T patent/DE602005027388D1/de active Active
- 2005-12-01 NZ NZ555184A patent/NZ555184A/en not_active IP Right Cessation
- 2005-12-01 WO PCT/EP2005/012834 patent/WO2006061136A2/en active Application Filing
- 2005-12-01 MX MX2007006504A patent/MX2007006504A/es active IP Right Grant
- 2005-12-01 AU AU2005313582A patent/AU2005313582B8/en not_active Ceased
- 2005-12-01 EP EP05811672A patent/EP1828151B1/en active Active
- 2005-12-01 CN CN2005800421635A patent/CN101072760B/zh not_active Expired - Fee Related
- 2005-12-01 KR KR1020077015604A patent/KR100890678B1/ko not_active IP Right Cessation
- 2005-12-01 JP JP2007544779A patent/JP4979590B2/ja not_active Expired - Fee Related
- 2005-12-01 DK DK05811672.4T patent/DK1828151T3/da active
- 2005-12-01 PL PL05811672T patent/PL1828151T3/pl unknown
- 2005-12-01 BR BRPI0518615-3A patent/BRPI0518615A2/pt not_active IP Right Cessation
- 2005-12-01 CA CA002589196A patent/CA2589196A1/en not_active Abandoned
- 2005-12-01 AT AT05811672T patent/ATE504580T1/de active
- 2005-12-07 TW TW094143269A patent/TWI349005B/zh not_active IP Right Cessation
- 2005-12-07 AR ARP050105106A patent/AR053987A1/es unknown
-
2007
- 2007-05-17 IL IL183293A patent/IL183293A0/en unknown
- 2007-05-24 NO NO20072609A patent/NO20072609L/no not_active Application Discontinuation
- 2007-06-04 ZA ZA200705018A patent/ZA200705018B/xx unknown
-
2008
- 2008-04-29 HK HK08104728.3A patent/HK1114840A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0518615A2 (pt) | 2008-11-25 |
| RU2402538C2 (ru) | 2010-10-27 |
| KR20070086979A (ko) | 2007-08-27 |
| JP2008522994A (ja) | 2008-07-03 |
| JP4979590B2 (ja) | 2012-07-18 |
| PL1828151T3 (pl) | 2011-09-30 |
| AU2005313582A8 (en) | 2011-06-16 |
| KR100890678B1 (ko) | 2009-03-26 |
| HK1114840A1 (en) | 2008-11-14 |
| CN101072760A (zh) | 2007-11-14 |
| RU2007120211A (ru) | 2009-01-20 |
| US7211573B2 (en) | 2007-05-01 |
| MX2007006504A (es) | 2007-06-22 |
| WO2006061136A2 (en) | 2006-06-15 |
| ZA200705018B (en) | 2010-04-28 |
| AU2005313582B2 (en) | 2011-06-02 |
| CN101072760B (zh) | 2011-12-28 |
| US20060122168A1 (en) | 2006-06-08 |
| TW200626568A (en) | 2006-08-01 |
| AR053987A1 (es) | 2007-05-30 |
| DE602005027388D1 (de) | 2011-05-19 |
| TWI349005B (en) | 2011-09-21 |
| IL183293A0 (en) | 2007-09-20 |
| EP1828151B1 (en) | 2011-04-06 |
| CA2589196A1 (en) | 2006-06-15 |
| AU2005313582A1 (en) | 2006-06-15 |
| EP1828151A2 (en) | 2007-09-05 |
| AU2005313582B8 (en) | 2011-06-16 |
| WO2006061136A3 (en) | 2006-08-03 |
| PT1828151E (pt) | 2011-06-16 |
| NZ555184A (en) | 2010-01-29 |
| DK1828151T3 (da) | 2011-05-16 |
| ATE504580T1 (de) | 2011-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20072609L (no) | Malonamid-derivater | |
| MXPA04009784A (es) | Tiazolidin-4-carbonitrilos y analogos y su uso como inhibidores de dipeptidil-peptidas. | |
| JP2008526999A5 (no) | ||
| NO20062689L (no) | Azabisykliske heterosykler som modulatorer for kannabinoidreseptorer | |
| AR037418A1 (es) | Derivados de benzotiazol | |
| CY1112127T1 (el) | 4-φαινυλαμινο-κιναζολιν-6-υλ-αμιδια | |
| NO20073465L (no) | Benzotiazol-derivater | |
| SE0104334D0 (sv) | Therapeutic agents | |
| NO20062370L (no) | Amidderivater | |
| NO20062704L (no) | Azabicykliske heterocykler som cannabinoide reseptormodulatorer | |
| NO20053748L (no) | Pyrrolopyridazinderivater. | |
| CY1106679T1 (el) | Αζαδικυκλικες ετεροκυκλικες ενωσεις ως τροποποιητες κανναβινοειδους υποδοχεα | |
| EA200601287A1 (ru) | Производные (3-оксо-3,4-дигидрохиноксалин-2-иламино) бензамида и родственные соединения в качестве ингибиторов гликогенфосфорилазы для лечения диабета и ожирения | |
| NO20083917L (no) | Malonamidderivater som gammasekretaseinhibitorer | |
| CA2592345A1 (en) | Piperidine and azetidine derivatives as glyt1 inhibitors | |
| DE60236719D1 (de) | Purinderivate als antagonisten an purinergen rezeptoren | |
| WO2007039781A3 (en) | 1,2,4-oxadioi.e derivatives with activity at the metabotropic clutamate receptors | |
| NO20052699L (no) | 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser. | |
| NO20070837L (no) | Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer. | |
| ATE399164T1 (de) | Antagonisten des opioidrezeptors | |
| NO20050903L (no) | Nye piperazinyl-pyrazinonderivater for behandling av 5HT-2A reseptorrelaterte forstyrrelser | |
| TW201111375A (en) | N-substituted cyclic amino derivative | |
| RU2003130070A (ru) | Производные бигуанида | |
| NO20070972L (no) | Benzyloksyderivater som MAOB-inhibitorer | |
| BR0318533A (pt) | azolidinacarbonitrilas e seu uso como inibidores de dpp-iv |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |